LSC - 2021 - Mapping of Kras mutations during chemical carcinogenesis
B. Sabine, M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), M. A. A. Pepe (mario.pepe@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. A. Giotopoulou (georgia.giotopoulou@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), M. Lianou (lianou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), A. Lamort (anne-sophie.lamort@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich)
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Sabine, M. Spella (magsp@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), M. A. A. Pepe (mario.pepe@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. A. Giotopoulou (georgia.giotopoulou@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), M. Lianou (lianou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), I. Giopanou (giopanou@upatras.gr / Department of Physiology, F. of Medicine, U. of Patras,Rio), A. Lamort (anne-sophie.lamort@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich), G. T. Stathopoulos (stathopoulos@helmholtz-muenchen.de / Comprehensive Pneumology Center, H. Zentrum,Munich). LSC - 2021 - Mapping of Kras mutations during chemical carcinogenesis. 1115
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
PP134 – Mapping of Kras mutations during chemical carcinogenesis Source: ERS Lung Science Conference 2021 Year: 2021
Mapping of Kras mutations during chemical carcinogenesis Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021
Mapping of KRAS mutations during chemical carcinogenesis Source: Virtual Congress 2020 – Inflammatory pathways in chronic airway diseases Year: 2020
LSC - 2021 - Mutational RNA signatures in environmentally-induced lung adenocarcinoma Source: Virtual Congress 2021 – New clinical and biological developments in lung cancer Year: 2021
LSC - 2017 - KRAS & TP53 mutations cause malignant mesothelioma Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017
LSC - 2021 - COL4A3 expression in asthmatic epithelium depends on intronic methylation and ZNF263 binding Source: Virtual Congress 2021 – Environment and air pollution Year: 2021
LSC - 2017 - CREB signaling in KRAS-driven lung adenocarcinoma Source: International Congress 2017 – Lung cancer: latest basic research on molecular alterations, tumour-immune system-microenvironment interplay and the metabolome Year: 2017
LSC - 2021 - Regulation of PA200 in lung cancer Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research Year: 2021
LSC - 2020 - Transcriptome signatures of tobacco carcinogens hint the alteration of TAF6 as a specific feature in smokers lung cancer Source: Virtual Congress 2020 – Novel methods, diagnostics and biomarkers of chronic lung diseases Year: 2020
NKX2-1 impacts prognosis in early stage NSCLC not harboring TP53 mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016
LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
LSC - 2020 - Comprehensive characterization of the immune landscape within different molecular subtypes of small cell lung cancer (SCLC) Source: Virtual Congress 2020 – Biological aspects of lung cancer Year: 2020
Target other gene point mutations: HER2 and rare EGFR mutations Source: ERS Research Seminar Year: 2015
Frequency and clinical-tomographic characterization of NSCLC with T790M mutation to TKI progression. Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019
Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014
LSC 2014 abstract - Phenotypic, transcriptomic and epigenetic plasticity of dendritic cells in the lung tumor microenvironment reflects imprinting by hypoxia exposure Source: International Congress 2014 – Thoracic tumours: news from the lab Year: 2014
p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005
Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
LSC - 2017 - Deregulated SOX2 drives a migratory signature in a novel organotypic model of bronchial dysplasia Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017
Mutation of TP53 and KRAS , and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005